Fritz Kunz is a seasoned pharmaceutical industry executive, who started his career at Sandoz Pharma in 1971. In 1992, Fritz was appointed chief financial officer at Stratec Medical, and from 1994 to 1998 he was CEO and a member of the Board of Directors of Institute Straumann. He was a member of the Board of Directors of Speedel, and Chairman from 2000 to 2008, when Novartis acquired the company. He is a member of the Board of Sentec. Fritz holds a PhD in Bio-organic Chemistry from the Swiss Federal Institute of Technology (ETH), Zurich, and was a post-doctoral fellow at Yale.
Bio-organic Chemistry